59 related articles for article (PubMed ID: 38723038)
1. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry MO; Abdel-Megeed RM
PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 ERĪ² deletion reveals roles in prostate.
Fenner A
Nat Rev Urol; 2020 Apr; 17(4):192-193. PubMed ID: 32157203
[No Abstract] [Full Text] [Related]
3. Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer.
Franco YL; Vaidya TR; Ait-Oudhia S
Breast Cancer (Dove Med Press); 2018; 10():131-141. PubMed ID: 30237735
[TBL] [Abstract][Full Text] [Related]
4. GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview.
Genta I; Chiesa E; Colzani B; Modena T; Conti B; Dorati R
Pharmaceutics; 2017 Dec; 10(1):. PubMed ID: 29271876
[TBL] [Abstract][Full Text] [Related]
5. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
[TBL] [Abstract][Full Text] [Related]
6. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
7. Curcumin and tumor immune-editing: resurrecting the immune system.
Bose S; Panda AK; Mukherjee S; Sa G
Cell Div; 2015; 10():6. PubMed ID: 26464579
[TBL] [Abstract][Full Text] [Related]
8. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
[TBL] [Abstract][Full Text] [Related]
9. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
10. Improved vectors and genome-wide libraries for CRISPR screening.
Sanjana NE; Shalem O; Zhang F
Nat Methods; 2014 Aug; 11(8):783-784. PubMed ID: 25075903
[No Abstract] [Full Text] [Related]
11. Development and applications of CRISPR-Cas9 for genome engineering.
Hsu PD; Lander ES; Zhang F
Cell; 2014 Jun; 157(6):1262-1278. PubMed ID: 24906146
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
13. Liposomal nanomedicines in the treatment of prostate cancer.
Kroon J; Metselaar JM; Storm G; van der Pluijm G
Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
[TBL] [Abstract][Full Text] [Related]
14. Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer.
Wang BL; Shen YM; Zhang QW; Li YL; Luo M; Liu Z; Li Y; Qian ZY; Gao X; Shi HS
Int J Nanomedicine; 2013; 8():3521-31. PubMed ID: 24101869
[TBL] [Abstract][Full Text] [Related]
15. Pegylated liposomal doxorubicin: a guide to its use in various malignancies.
Lyseng-Williamson KA; Duggan ST; Keating GM
BioDrugs; 2013 Oct; 27(5):533-40. PubMed ID: 24018470
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.
Fang LY; Izumi K; Lai KP; Liang L; Li L; Miyamoto H; Lin WJ; Chang C
Cancer Res; 2013 Sep; 73(18):5633-46. PubMed ID: 23878190
[TBL] [Abstract][Full Text] [Related]
17. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.
Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL
Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
